Preparation and characterization of anti-tubercular drugs encapsulated in polymer micelles

Lönnroth, 2010, Tuberculosis control and elimination 2010–50: cure, care, and social development, Lancet, 375, 1814, 10.1016/S0140-6736(10)60483-7 Sosnik, 2010, New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery, Adv. Drug Deliv. Rev., 62, 547, 10.1016/j.addr.2009.11.023 Aziz, 2006, Epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis, Lancet, 368, 2142, 10.1016/S0140-6736(06)69863-2 Du Toit, 2006, Tuberculosis chemotherapy: current drug delivery approaches, Respir. Res., 7, 118, 10.1186/1465-9921-7-118 Mitchison, 1985, The action of antituberculosis drugs in short-course chemotherapy, Tubercle, 66, 219, 10.1016/0041-3879(85)90040-6 Singh, 2001, A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem, Int. J. Pharm., 228, 5, 10.1016/S0378-5173(01)00754-2 Sahana, 2008, PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug, J. Pharmaceut. Sci., 97, 1530, 10.1002/jps.21158 Sosnik, 2008, Polymeric nanocarriers: new endeavors for the optimization of the technological aspects of drugs, Recent Pat. Biomed. Eng., 1, 43, 10.2174/1874764710801010043 Moretton, 2010, Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles, Colloids Surfaces B Biointerfaces, 79, 467, 10.1016/j.colsurfb.2010.05.016 Chiappetta, 2011, Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles, Biomaterials, 32, 2379, 10.1016/j.biomaterials.2010.11.082 Chiappetta, 2013, Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV, Nanomedicine, 8, 223, 10.2217/nnm.12.104 Mundargi, 2008, Nano/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives, J. Contr. Release, 125, 193, 10.1016/j.jconrel.2007.09.013 Makadia, 2011, Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier, Polymers, 3, 1377, 10.3390/polym3031377 Pandey, 2006, Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs, Drug Deliv., 13, 287, 10.1080/10717540500398076 Nakashima, 2006, Aggregation of water-soluble block copolymers in aqueous solutions: recent trends, Adv. Colloid Interface Sci., 123, 75, 10.1016/j.cis.2006.05.016 Chiappetta, 2007, Poly (ethylene oxide)–poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs, Eur. J. Pharm. Biopharm., 66, 303, 10.1016/j.ejpb.2007.03.022 Wanka, 1990, The aggregation behavior of poly (oxyethylene)–poly (propylene oxide)–poly (ethylene oxide) block copolymers in aqueous solution, Colloid Polym. Sci., 268, 101, 10.1007/BF01513189 Pandit, 1998, Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels, Int. J. Pharm., 167, 183, 10.1016/S0378-5173(98)00074-X Hvidt, 1994, Micellization and gelation of aqueous solutions of a triblock copolymer studied by rheological techniques and scanning calorimetry, J. Phys. Chem., 98, 12320, 10.1021/j100098a030 Alexandridis, 1994, Micellization of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association, Macromolecules, 27, 2414, 10.1021/ma00087a009 Bahadur, 1991, Block copolymers: a special class of surfactants, Tenside Surfactants Deterg., 28, 173, 10.1515/tsd-1991-280310 Alexandridis, 1995, Poly (ethylene oxide)- poly (propylene oxide)- poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling, Colloid. Surface. Physicochem. Eng. Aspect., 96, 1, 10.1016/0927-7757(94)03028-X Yang, 2000, Small-angle neutron scattering investigation of the temperature-dependent aggregation behavior of the block copolymer Pluronic L64 in aqueous solution, Langmuir, 16, 8555, 10.1021/la000008m Lundsted, 1976, The applications of block copolymer polyol surfactants, 113 Hunter, 1995, Enhancement of antibiotic susceptibility and suppression of Mycobacterium avium complex growth by poloxamer 331, Antimicrob. Agents Chemother., 39, 435, 10.1128/AAC.39.2.435 Sheth, 2017, Salt effect on solubilization of hydrophobic drugs in block copolymeric micelles and investigation of their in vitro and in vivo oral efficiency, J. Drug Deliv. Sci. Technol., 39, 531, 10.1016/j.jddst.2017.05.007 Hubatsch, 2007, Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers, Nat. Protoc., 2, 2111, 10.1038/nprot.2007.303 Augustijns, 1993, Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporine A transport, Biochem. Biophys. Res. Commun., 197, 360, 10.1006/bbrc.1993.2487 Yilmaz, 2012, HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey, J. Chromatogr. Sci., 50, 914, 10.1093/chromsci/bms090 Meghana, 2012, Development and validation of RP-HPLC method for simultaneous estimation of clonazepam and propranolol hydrochloride in bulk and pharmaceutical dosage forms, Inventi Rapid Pharm Anal. Qual. Assur., 3, 12 Kumari, 2015, A validated liquid chromatographic method for the determination of rifampicin and isoniazid in pharmaceutical formulations, Br. J. Pharmaceut. Res., 7, 299, 10.9734/BJPR/2015/12562 Sachdeva, 2002, Characterisation & drug susceptibility patterns of extrapulmonary mycobacterial isolates, Indian J. Med. Res., 115, 102 Rangel-Yagui, 2005, Micellar solubilization of drugs, J. Pharm. Pharmaceut. Sci., 8, 147 Mall, 1996, Dissolution behaviour of sulphonamides into sodium dodecyl sulfate micelles: a thermodynamic approach, J. Pharmaceut. Sci., 85, 75, 10.1021/js950225l Allen, 1995, Pharmacokinetics of long-circulating liposomes, Adv. Drug Deliv. Rev., 16, 267, 10.1016/0169-409X(95)00029-7 Canto, 1999, Piroxicam encapsulated in liposomes: characterization and in vivo evaluation of topical anti-inflammatory effect, Drug Dev. Ind. Pharm., 25, 1235, 10.1081/DDC-100102293 Gref, 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245 Dutt, 2003, Rotational diffusion of hydrophobic probes in Brij-35 micelles: effect of temperature on micellar internal environment, J. Phys. Chem. B, 107, 10546, 10.1021/jp034708m Torchilin, 2001, Structure and design of polymeric surfactant-based drug delivery systems, J. Contr. Release, 73, 137, 10.1016/S0168-3659(01)00299-1 Kadam, 2009, Solubilization of poorly water-soluble drug carbamezapine in Pluronic® micelles: effect of molecular characteristics, temperature and added salt on the solubilizing capacity, Colloids Surfaces B Biointerfaces, 72, 141, 10.1016/j.colsurfb.2009.03.027 Raval, 2017, Systematic characterization of Pluronic® micelles and their application for solubilization and in vitro release of some hydrophobic anticancer drugs, J. Mol. Liq., 230, 473, 10.1016/j.molliq.2017.01.065 Kabanov, 1989, The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: micelles as microcontainers for drug targeting, FEBS Lett., 258, 343, 10.1016/0014-5793(89)81689-8 Saettone, 1988, Solubilization of tropicamide by poloxamers: physicochemical data and activity data in rabbits and humans, Int. J. Pharm., 43, 67, 10.1016/0378-5173(88)90060-9 Krishna, 1989, Micellar solubilization of a new antimalarial drug, β‐arteether, J. Pharmaceut. Sci., 78, 574, 10.1002/jps.2600780713 Marini, 2003, Drug-excipient compatibility studies by physico-chemical techniques; the case of atenolol, J. Therm. Anal. Calorim., 73, 547, 10.1023/A:1025478129417 Jindal, 2015, Nevirapine loaded Poloxamer 407/Pluronic P123 mixed micelles: optimization of formulation and in vitro evaluation, Colloids Surfaces B Biointerfaces, 129, 100, 10.1016/j.colsurfb.2015.03.030 Singla, 2018, Sodium deoxycholate mediated enhanced solubilization and stability of hydrophobic drug Clozapine in pluronic micelles, Spectrochim. Acta Mol. Biomol. Spectrosc., 191, 143, 10.1016/j.saa.2017.10.015 Aungst, 2000, Intestinal permeation enhancers, J. Pharmaceut. Sci., 89, 429, 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J DIMITRIJEVIC, 2000, Effects of some non‐ionic surfactants on transepithelial permeability in Caco‐2 cells, J. Pharm. Pharmacol., 52, 157, 10.1211/0022357001773805 Takahashi, 2002, Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs, Int. J. Pharm., 246, 85, 10.1016/S0378-5173(02)00347-2 Saha, 2000, Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers, Eur. J. Pharm. Biopharm., 50, 403, 10.1016/S0939-6411(00)00113-2 D'Arcy Hart, 1971, Effects of non‐ionic surfactants that modify experimental tuberculosis on lipase activity of macrophages, Br. J. Pharmacol., 43, 190, 10.1111/j.1476-5381.1971.tb07168.x